Anna C. Maurer

Anna completed her PhD in Biological and Biomedical Sciences at Harvard Medical School, where she studied adeno-associated virus (AAV) capsid assembly mechanisms and vector engineering. She is currently a CIRM Postdoctoral Fellow at the University of California, Berkeley and a Primary Investigator with the FNIH Bespoke Gene Therapy Consortium, where she is researching mechanisms of AAV vector genome expression and regulation. Anna is an inventor on multiple patents on recombinant AAV technologies.